Pedroso MI, Bravo AT, Rodríguez LH

Language: Spanish
References: 22
Page:
PDF size: 217.57 Kb.

ABSTRACT

Introduction: It is very evident the great relationship that has the smocking with the illness, being very few the patients that present obstructive chronic pulmonar disease for other objective causes: This work pretends to evidence the main cause of the obstructive chronic pulmonar disease in our study. Methods: It was carried out an observational, prospective, longitudinal study, applied to 50 patients that attended the consultation of Physical Medicine and Rehabilitation in the one year period in the Surgical Medical Investigations Center, where it was applied a program of exercises and the smock Index. All the patients were registered in a clinical record. A database was made using the statistical package SPSS 11. 0, it was processed by means of technical descriptive (percentages, mediates, medium, fashion, standard deviation). The final reports of the results were charts and graphics. Results. It was carried out: The average of annual smock index was of 147, 7 boxes (of 20 cigarettes). there are 13 patients that were not smoking (I activate) and 50 % of the patients had an index of 25 annual boxes, that is to say, they smoked up to 25 boxes in the year. 75 % smoked up to 96 boxes a year. There was a patient that had smock index of 2000 boxes a year (5,47 daily boxes) Like average the patients of the sample smoked among 23 -38,5años, Quantity of cigarettes: the average of cigarettes a day is 18 to 32 cigarettes a day. Conclusions: It was demonstrated that in general the patient with obstructive chronic pulmonar disease is or you/he/she has been smoking at least of 20 daily cigarettes during 20 years.

REFERENCES

1. Fiore M.C, Jaen C.R ,. Baker T.B,. Bailey W.C , Benowitz N.,. Curry N S. Treating Tobacco Use and Dependence: 2008 update. Clinical practice guidelineDepartment of Health and Human Service, (2008)

2. U.S. Department of Health and Human Services. A Report of the Surgeon General. Preventing Tobacco Use Among Youth and Young Adults: We CAN Make the Next Generation Tobacco-Free. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health [accessed 2018 Mar 22].

3. TRABAJO FIN DE GRADO .EPOC y TABAQUISMO JAUME ALBIOL CHIVAConvocatoria: FEBRERO 2015

4. Who.int [Internet]. España: Who; 2014 [actualizado 20 dic 2014; Disponible en:http://www.who.int/tobacco/health_priority/es/

5. R. Lozano,M. Naghavi,K. Foreman,S. Lim,K. Shibuya,V. Aboyans Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010 Lancet, 380 (2012), pp. 2095-2128 http://dx.doi.org/10.1016/S0140-6736(12)61728-0 Medline

6. El tabaquismo y la enfermedad pulmonar obstructiva crónica (EPOC).consejos de exfumadores. https://www.cdc.gov/spanis

7. Centers for Disease Control and Prevention. What Is COPD? [last updated 2017 Aug 4; accessed 2018 Mar 22].

8. National Heart, Lung, and Blood Institute. What Is COPD?External [accessed 2018 Mar 22].

9. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 [accessed 2018 Mar 22].

10. Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease Among Adults—United States, 2011. Morbidity and Mortality Weekly Report 2012;61(46):938–43 [accessed 2018 Mar 22]

11. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233–9.

12. Who.int [Internet]. España: Who; 2014 [actualizado 20 dic 2014; Disponible en: http://www.who.int/features

13. Año SEPAR 2015-16: EPOC y tabaco. ¿Qué podemos esperar? DOI: 10.1016/j.arbres.2015.11.002

14. M. Miravitlles,J.J. Soler-Cataluña,M. Calle,J. Molina,P. Almagro,J.A. Quintano .Tratamiento farmacológico de la EPOC estable Arch Bronconeumol, 48 (2012), pp. 247-257 http://dx.doi.org/10.1016/j.arbres.2012.04.001 Medline

15. M. Miravitlles,J.J. Soler-Cataluña,M. Calle,J. Molina,P. Almagro,J.A. Quintano .Spanish guideline for COPD (GesEPOC). Update 2014 Arch Bronconeumol., 50 (2014), pp. S1-16

16. Enfermos por tabaquismo mejoran su vida con la rehabilitación respiratoria .REDACCION MÉDICA. Mar 30 mayo 2017 https://www.redaccionmedica.com/secciones/privada/enfermos-por-tabaquismo-mejoran-su-vida-con-la-rehabilitacion-respiratoria-1185

17. Tesis de grado .influencia del cigarrillo en la presencia del epoc andrade velásquez xiomara betzabeth ,lema tixi grace gabriela.

18. Sívori M, Fernández R.. Clasificación de EPOC GOLD 2018: ¿otra oportunidad perdida? Rev. am. med. respir. [Internet]. 2018 Jun [citado 2019 Mar 02]; 18(2): 140-142. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1852-236X2018000200012&lng=es.

19. GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease 2018 Report: GOLD Executive Summary. Acceso el 1 de Marzo de 2018 en www.copdgold.com

20. WHO World Health Organization. WHO Report on the Global Tobacco Epidemic 2015. Acceso el 1 de Marzo en: www.who.int/tobacco/global_report/2015/en/

21. En este aspecto se coincide con. Recomendaciones para el Diagnóstico y Tratamiento de la Enfermedad Pulmonar Obstructiva Crónica (EPOC) Guia alat epoc_abril2011Edición 1 Enero 2011 www.alatorax.org

22. Vinaccia S, Quiceno JM, Zapata C, Obesso S, Quintero DC. Calidad vida relacionada con la salud y emociones negativas en pacientes con diagnóstico de EPOC. Psicología desde el Caribe .Universidad del Norte. 2006 ,18: 89-108.